Atlassian (NASDAQ:TEAM) CEO Sells $1,123,842.30 in Stock

Atlassian Corporation PLC (NASDAQ:TEAM) CEO Michael Cannon-Brookes sold 7,665 shares of Atlassian stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $146.62, for a total value of $1,123,842.30. Following the transaction, the chief executive officer owned 191,625 shares in the company, valued at approximately $28,096,057.50. The trade was a 3.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Michael Cannon-Brookes also recently made the following trade(s):

• On Friday, November 21st, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $144.02, for a total transaction of $1,103,913.30.
• On Wednesday, November 19th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.63, for a total value of $1,131,583.95.
• On Monday, November 17th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.41, for a total value of $1,129,897.65.
• On Thursday, November 13th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $153.77, for a total value of $1,178,647.05.
• On Monday, November 10th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $158.00, for a total value of $1,211,070.00.
• On Friday, November 7th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $155.58, for a total transaction of $1,192,520.70.
• On Wednesday, November 5th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $162.66, for a total transaction of $1,246,788.90.
• On Monday, November 3rd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $172.78, for a total transaction of $1,324,358.70.
• On Friday, October 31st, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $167.61, for a total transaction of $1,284,730.65.
• On Wednesday, October 29th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $160.40, for a total transaction of $1,229,466.00.

Atlassian Stock Up 1.8%

TEAM stock traded up $2.59 during midday trading on Tuesday, hitting $149.04. The company’s stock had a trading volume of 2,527,852 shares, compared to its average volume of 2,514,477. The firm has a 50-day simple moving average of $157.99 and a 200-day simple moving average of $181.10. The firm has a market capitalization of $39.21 billion, a P/E ratio of -209.91, a PEG ratio of 34.69 and a beta of 0.95. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 0.72. Atlassian Corporation PLC has a 52-week low of $139.70 and a 52-week high of $326.00.

Atlassian (NASDAQ:TEAM) last posted its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.21. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.40 billion. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The company’s revenue was up 20.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 earnings per share. Atlassian has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts forecast that Atlassian Corporation PLC will post -0.34 EPS for the current year.

Wall Street Analysts Forecast Growth

TEAM has been the subject of a number of analyst reports. Zacks Research raised Atlassian from a “strong sell” rating to a “hold” rating in a research report on Monday, November 3rd. Wells Fargo & Company assumed coverage on shares of Atlassian in a report on Tuesday, September 30th. They set an “overweight” rating and a $216.00 price target for the company. Stephens reduced their price objective on shares of Atlassian from $221.00 to $202.00 and set an “equal weight” rating on the stock in a report on Monday, August 11th. Bank of America assumed coverage on shares of Atlassian in a research report on Tuesday, September 23rd. They set a “neutral” rating and a $200.00 price objective for the company. Finally, Piper Sandler restated an “overweight” rating and issued a $300.00 price target on shares of Atlassian in a research note on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $240.00.

Hedge Funds Weigh In On Atlassian

Several large investors have recently bought and sold shares of the stock. Capco Asset Management LLC purchased a new stake in shares of Atlassian in the 2nd quarter valued at about $25,000. Physician Wealth Advisors Inc. boosted its holdings in shares of Atlassian by 60.4% in the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after acquiring an additional 61 shares during the period. Atlantic Union Bankshares Corp grew its position in shares of Atlassian by 19,900.0% during the third quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock worth $32,000 after acquiring an additional 199 shares during the last quarter. Smithfield Trust Co raised its position in Atlassian by 90.7% in the 1st quarter. Smithfield Trust Co now owns 164 shares of the technology company’s stock valued at $34,000 after purchasing an additional 78 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in Atlassian by 447.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after purchasing an additional 161 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Atlassian Company Profile

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.